Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New computer tool aims to boost cirrhosis care in hospitals

NCT ID NCT05967273

First seen Apr 02, 2026 · Last updated Jun 23, 2026 · Updated 8 times

Summary

This study tests a computer program called CirrhosisRx that helps doctors follow national guidelines when treating cirrhosis patients in the hospital. Over 2,100 adults with cirrhosis will be randomly assigned to either usual care or care guided by this tool. The goal is to see if the tool improves adherence to quality measures and patient outcomes like survival.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of California San Francisco Medical Center

    RECRUITING

    San Francisco, California, 94143, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

CirrhosisRx clinical decision support system (a computer tool for doctors)

What this could lead to

If it works, this could show that a simple computer tool helps doctors provide better, guideline-based care for cirrhosis patients in the hospital.

What could go wrong

This is a pragmatic trial testing a process, not a new drug. The tool may not change outcomes significantly, and results may not apply to all hospitals.

Conditions

The condition(s) this trial relates to.

cirrhosis of liver Fibrosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.